Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Pomegranate nanoparticle mitigates cisplatin-induced testicular toxicity and improves cisplatin anti-cancer efficacy in Ehrlich carcinoma model

2023Journal of King Saud University - ScienceJournalOpen access

10.1016/j.jksus.2023.102631 Full text7 citations

Authors

11 authors across 8 institutions in 4 countries.

Mohammed QariFirst author
Steve HarakehCorresponding
Isaac O. Akefe
- University of Jos (NG)
Saber H. Saber
- Assiut University (EG)
Rajaa Al-Raddadi
Zakaria Y. Abd Elmageed
Turki Alamri
Nagla A. El-Shitany
- Tanta University (EG)
as printed: Nagla El-Shitany
Soad Shaker
as printed: Soad S. Ali
Mohammed S. Almuhayawi
Shaker A. MousaSenior authorCorresponding
as printed: Shaker Mousa

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Chemotherapy-induced organ toxicity mitigationlevel 3 · 1.00
Pomegranate: compositions and health benefitslevel 3 · 0.99
Sesame and Sesamin Researchlevel 3 · 0.97

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2023 · Journal of King Saud University - Science · 7 citations
https://openalex.org/W4323322318

Pomegranate nanoparticle mitigates cisplatin-induced testicular toxicity and improves cisplatin anti-cancer efficacy in Ehrlich carcinoma model · Sankore